BIOMAT Database Logo BIOMAT Database Logo

An enzyme-linked immunosorbent assay for antibodies against acid soluble skeletal muscle antigen in myasthenia gravis. 1999

M Annamma, and C Sarada, and V V Radhakrishnan
Department of Pathology, Sree Chitra Tirunal Institute for Medical Science and Technology, Thiruvananthapuram, Kerala State, India.

An enzyme-linked immunosorbent assay (ELISA) system has been developed for measuring serum antibodies against citric-acid extract of human skeletal muscles. With this assay, 80% of myasthenia patients with thymoma gave positive results. No sera from patients with neurological diseases other than myasthenia gravis (MG) gave positive results. The result of this study indicates that the ELISA system is useful as an adjunct for the diagnosis of MG particularly in the patients associated with thymoma and that the ELISA method can also be used as a prognostic marker following thymectomy in patients with MG.

UI MeSH Term Description Entries
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009157 Myasthenia Gravis A disorder of neuromuscular transmission characterized by fatigable weakness of cranial and skeletal muscles with elevated titers of ACETYLCHOLINE RECEPTORS or muscle-specific receptor tyrosine kinase (MuSK) autoantibodies. Clinical manifestations may include ocular muscle weakness (fluctuating, asymmetric, external ophthalmoplegia; diplopia; ptosis; and weakness of eye closure) and extraocular fatigable weakness of facial, bulbar, respiratory, and proximal limb muscles. The disease may remain limited to the ocular muscles (ocular myasthenia). THYMOMA is commonly associated with this condition. Anti-MuSK Myasthenia Gravis,MuSK MG,MuSK Myasthenia Gravis,Muscle-Specific Receptor Tyrosine Kinase Myasthenia Gravis,Muscle-Specific Tyrosine Kinase Antibody Positive Myasthenia Gravis,Myasthenia Gravis, Generalized,Myasthenia Gravis, Ocular,Anti MuSK Myasthenia Gravis,Generalized Myasthenia Gravis,Muscle Specific Receptor Tyrosine Kinase Myasthenia Gravis,Muscle Specific Tyrosine Kinase Antibody Positive Myasthenia Gravis,Myasthenia Gravis, Anti-MuSK,Myasthenia Gravis, MuSK,Ocular Myasthenia Gravis
D011379 Prognosis A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations. Prognostic Factor,Prognostic Factors,Factor, Prognostic,Factors, Prognostic,Prognoses
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D004797 Enzyme-Linked Immunosorbent Assay An immunoassay utilizing an antibody labeled with an enzyme marker such as horseradish peroxidase. While either the enzyme or the antibody is bound to an immunosorbent substrate, they both retain their biologic activity; the change in enzyme activity as a result of the enzyme-antibody-antigen reaction is proportional to the concentration of the antigen and can be measured spectrophotometrically or with the naked eye. Many variations of the method have been developed. ELISA,Assay, Enzyme-Linked Immunosorbent,Assays, Enzyme-Linked Immunosorbent,Enzyme Linked Immunosorbent Assay,Enzyme-Linked Immunosorbent Assays,Immunosorbent Assay, Enzyme-Linked,Immunosorbent Assays, Enzyme-Linked
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly

Related Publications

M Annamma, and C Sarada, and V V Radhakrishnan
An enzyme-linked immunosorbent assay for antibodies against saline-soluble muscle components in myasthenia gravis.
November 1986, Journal of immunological methods,
M Annamma, and C Sarada, and V V Radhakrishnan
Enzyme-linked immunosorbent assay for detection of antibodies to extractable muscle antigens in myasthenia gravis.
June 1986, Acta neurologica Scandinavica,
M Annamma, and C Sarada, and V V Radhakrishnan
Myasthenia gravis. Antibodies to an acid-soluble antigen in striated muscle.
March 1972, Clinical and experimental immunology,
M Annamma, and C Sarada, and V V Radhakrishnan
Antibodies against saline-soluble components of skeletal muscle in myasthenia gravis.
March 1988, Journal of neurology,
M Annamma, and C Sarada, and V V Radhakrishnan
Enzyme-linked immunosorbent assay for antibody against the nicotinic acetylcholine receptor in human myasthenia gravis.
February 1984, Annals of neurology,
M Annamma, and C Sarada, and V V Radhakrishnan
Enzyme immunoassay for measuring antibodies against skeletal muscle in patients with myasthenia gravis.
November 1990, Clinical chemistry,
M Annamma, and C Sarada, and V V Radhakrishnan
An enzyme-linked immunosorbent assay for antistriational antibodies associated with myasthenia gravis and thymoma: comparison with indirect immunofluorescence.
May 1983, Journal of immunological methods,
M Annamma, and C Sarada, and V V Radhakrishnan
Use of an enzyme-linked immunosorbent assay for screening hybridoma antibodies against hepatitis B surface antigen.
January 1982, Journal of immunological methods,
M Annamma, and C Sarada, and V V Radhakrishnan
An enzyme-linked immunosorbent assay for detection of antibodies against bovine pestivirus.
September 1993, New Zealand veterinary journal,
M Annamma, and C Sarada, and V V Radhakrishnan
[Enzyme-linked-immunosorbent assay (ELISA) for demonstrating antibodies against toxoplasmosis].
April 1983, Klinische Monatsblatter fur Augenheilkunde,
Copied contents to your clipboard!